CDB Drugs in Pets Market By Grade Type (Therapeutic Grade, Food Grade), By Application (Joint Pain, Anxiety/Stress, Epilepsy, General Health/Wellness), By Distribution Channel (Veterinary Hospital Pharmacies, Pet-Shops, E-commerce Platforms), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2021-2031

Global CDB Drugs in Pets Market is Driven by Increased Awareness Regarding the CBD Drugs for Pets Coupled with Adoption of Such Products Among Pet Owners

Market.US announces publication of its most recently generated research report titled, “Global CDB Drugs in Pets Market by Grade Type (Therapeutic Grade and Food Grade), Application (Joint Pain, Anxiety/Stress, Epilepsy, General Health/Wellness, and Other Applications), Distribution Channel (Veterinary Hospital Pharmacies, Pet-Shops, and E-commerce Platforms), and by Region – Global Forecast 2021 to 2031”, which offers a holistic view of the global CDB drugs in pets market through systematic segmentation that covers every aspect of the target market.

Global CDB drugs in pets market is projected to be 121,200.0 USD Thousands in 2021 to reach 934,885.8 USD Thousands by 2031 at a CAGR of 23.1%.

Cannabidiol (CBD) is a chemical substance found in the Cannabis Sativa plant. CBD is classified as Schedule 4 drug which is non-psychoactive therapeutic medicine in nature. Cannabis plants are bifurcated into marijuana and hemp. These plants produce two components such as, CBD and Tetrahydrocannabinol (THC) with varying medicinal properties according to the percentage these components.

Marijuana consists of higher percentage of THC content up to 10-15 percent, which becomes psychoactive and negatively affects pet’s overall health. Mostly hemp is utilized for medical purposes as it consists of less than 0.3 percent of THC concentration and higher concertation of CBD. These drugs help in order to provide relief from common pet diseases such as, anxiety, joint support pain, etc.

Owing to this increase in the prominence of various chronic diseases such as, cardiovascular diseases, digestive imbalance, arthritis, nausea, stress, and cancer are increasing trend towards drug development and treatments methods which is expected to favorably impact the need for CBD drug in the foreseeable future.

These drugs are available in the form of cannabis oils, capsules and edible treats. CBD medicines for dogs are within the federally controlled narcotic category and must be purchased with a physician consultation to ensure correct dose levels are provided to pets. Presently, cats and dogs are the most common pets that people adopts, and CBD drugs are most effective and commonly used in the treatment of these pets.

When it comes to cat care, the younger generation, particularly millennials, has grown quite cautious. According to the International Association, Degenerative Joint Disease (DJD) is present in up to 90% of all cats, with an estimated 50% of them showing medical indications of impairment due to joint pain. As a result, such elements contribute to the economic growth of this market.

Global CDB Drugs in Pets Market Revenue ( US$ Thousands), 2021–2031

According to Food and Drug Administration (FDA), the trials conducted on Cannabidiol (CBD) drugs on veterinary treatments have found favorable effects on the mental health of pets. These drugs have found effective on anxiety, phobias, dementia, obsessive compulsions, etc. In order to treat these diseases, CBD drugs are being recommended by the veterinary physicians affecting economic growth of positively.

The COVID-19 pandemic has put tremendous pressure on respective healthcare systems, due to lack of adequate infrastructure and resource availability. Therefore, responding to such public health emergencies and successfully minimizing their corresponding impacts, requires the effective utilization of every healthcare resource.

Failure to mitigate any damages to the healthcare industry could expose this system to severe discrepancies, particularly when these services are most needed, and may have long-term effects on the health and well-being of a given population. In order to cope with this pandemic, the WHO, various governments, and the international community as a whole have also taken measures to address any stigmas concerning this virus.

Several economies across the globe are facing economic crises due to the onset of this pandemic. Although public policy measures have been implemented to curb the spread of COVID-19, these measures have caused major operational disruptions for numerous companies, including those engaged in the healthcare industry. The isolation of employees, supply chain disruptions, and sudden reductions in customer demand have led to more detrimental issues than initially expected. For most individuals, the loss of income during this period has become a permanent loss, suddenly bringing with it unexpected pressures on both working capital and asset liquidity.

Global CDB Drugs in Pets Market Attractiveness Analysis by Grade Type, 2022–2031

The global CBD pet drugs market is segmented on the basis of grade type, application, distribution channel, and by region. As per the grade type market segmentation of this industry, the therapeutic grade sub-segment is expected to account for a majority revenue share of this target industry. In terms of application market segmentation, the epilepsy sub-segment is expected to generate a majority revenue share over the forecast period.

Based on distribution channel, pet-shops accounts for the majority revenue share, followed by e-commerce platforms. On the basis of regions, the market in North America is projected to account for the majority share, in terms of revenue, for the global CBD pet drugs market, and this sub-segment is projected to maintain its respective market position over the forecast period.

The research report on the global CDB drugs in pets market includes profiles of some of the major companies such as

• Petco Health & Wellness Company Inc.
• Charlotte’s Web
• Joy Organics Llc
• Pet Relief
• HolistaPet
• CBD Living
• Fomo Bones
• Wet Noses Inc.
• Honest Paws LLC.
• Canna-Pet LLC
• others.

Global CDB Drugs in Pets Market Segmentation Based on Grade Type, Application, Distribution Channel, and Region

Based on Grade Type:

• Therapeutic Grade
  • Pet Supplements
  • Pet CBD Oil
• Food Grade
  • Treats
  • Chews

Based on Application:

• Joint Pain
• Anxiety/Stress
• Epilepsy
• General Health/Wellness
• Other Applications

Based on Distribution Channel:

• Veterinary Hospital Pharmacies
• Pet-Shops
• E-commerce Platforms

Based on Regions:

• North America
• Europe
• Asia Pacific
• South America
• MEA

For the CDB Drugs in Pets Market research study, the following years have been considered to estimate the market size: